DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: MAYZENT (siponimod)
       *****************************************************
       #Post#: 2803--------------------------------------------------
       Woman w/SPMS in Australia unable to get siponimod, turns to GoFu
       ndMe
       By: agate Date: February 6, 2020, 1:01 am
       ---------------------------------------------------------
       This article is badly garbled in spots but it concerns an
       Australian woman (in her 60s, I believe) who has had MS for 35
       years. Since hers is SPMS, she would like to take siponimod but
       was denied coverage through the health care system. This looks
       like a situation where she is no longer having relapses and so
       isn't considered a good candidate for siponimod but that part
       isn't made clear.
       From the Glen Innes [Australia] Examiner (February 6, 2020):
       Note: In the article PBS = Pharmaceutical Benefits Scheme
  HTML https://www.gleninnesexaminer.com.au/story/6616818/glen-innes-ms-survivor-wants-to-be-the-first-australian-to-use-new-wonder-drug/
       This notice from MS Australia (December 20, 2019) makes the
       situation somewhat clearer:
  HTML https://www.msaustralia.org.au/news-blogs/latest-news/pbs-listing-siponimod-brand-name-mayzent%C2%AE-spms-not-recommended-pbac
       *****************************************************